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Summary Because vanadate ion is a potent mitogen and accumulates in the gut of rodents fed vanadate
supplements, effects of ammonium metavanadate in drinking water (10ppm or 20ppm) were studied on the
development of large bowel neoplasms in mice treated with 1,2-dimethylhydrazine (DMH) (20mgkg-1
weekly for 20 weeks). In the colon at 30 weeks DMH treatment caused a 14% increase in RNA content, an
18% increase in DNA content, and 33% deeper crypts. Vanadate at either 10ppm or 20ppm decreased RNA
content by -11%. Although vanadate increased thymidine incorporation 210% to 550% compared with
controls, it had no influence on the attack rate, incidence, or histological type of tumours induced by DMH.
One of fifteen essential trace elements in man
(Casey & Hambidge, 1980; WHO, 1973; Golden &
Golden, 1981; Kingsnorth, 1984), vanadium is a
potent mitogen in vitro, promoting cell proliferation
in cultured mouse mammary gland (Hori, 1980),
human fibroblasts (Carpenter, 1981), and mouse
3T3 and 3T6 cells (Smith, 1983). Rising vanadium
levels in the environment resulting from the
combustion of fossil fuels (Sabbioni, 1981) have
increased the risk of absorption and accumulation
of vanadium in human beings. Because the digestive
tract accumulates vanadium (Parker, 1978; Sharma,
1980), any mitogenic action of vanadium promoting
cell proliferation could also promote chemical
neoplasia (Farber, 1984). Our experiments examined
effects of ingested vanadate on dimethylhydrazine-
induced colonic cancer.
Materials and methods
Male CD-1 mice (n=115) (Charles River Breeding
Laboratories, Wilmington, MA: 40 days; 26-28g)
were housed in plastic containers (4-6 per cage)
under 12h light-dark cycles beginning at 6.00a.m.
for 2 weeks before the start of the experiment. Free
access was allowed to Purina Rodent Chow and to
water or aqueous ammonium metavanadate.
1, 2-dimethylhydrazine (DMH) (Aldrich Chemical
Co., Inc., Milwaukee, WI) dissolved in 0.001 M
EDTA immediately before use and brought to
pH 6.5 with 1 M sodium bicarbonate was given by
subcutaneous injection (20mgkg-1) weekly for 20
weeks. Ammonium metavanadate (NH4VO3),
(analytical grade, Aldrich) was added to drinking
water to 10ppm or 20ppm vanadium. Solutions
were renewed every 2-3 days. The total dose of
vanadate ion estimated from water consumpti6n
was 20mg in mice fed 10ppm ammonium
metavanadate and 40 mg in mice fed 20 ppm.
Mice were randomised into 6 groups:
(1)
(2)
(3)
(4)
(5)
(6)
No treatment (control group) (n = 16)
Drinking water containing 10ppm vanadate
(V1O) (n= 16)
Drinking water containing 20 ppm vanadate
(V20) (n= 17)
DMH alone (DMH) (n=23)
DMH plus drinking water containing 10 ppm
vanadate (V1O-DMH) (n=23)
DMH plus drinking water containing 20ppm
vanadate (V20-DMH) (n =20)
Thirty minutes before death by cervical
dislocation, 10 weeks after the last DMH injection,
mice were injected subcutaneously with 25pCi
[3H]thymidine (6.7 Cimmol- 1; New England
Nuclear Corp., Boston, MA). The colon was
removed, slit lengthwise, and washed in ice-cold
saline solution. Tumours were mapped and excised
for histological study. Full-thickness 2cm long
colonic specimens without a neoplastic component
were removed from comparable segments of the
colon in all animals and were stored at - 300 for
subsequent biochemical and morphometric analysis.
DNA specimens were 5-7 cm from the anal verge;
specimens for crypt depth measurements were 7-
9 cm from the anal verge.
DNA content was determined by the method of
Burton (Burton, 1968). Radioactivity in aliquots
from the acid-insoluble fraction was counted in 3 ml
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PCS scintillation fluid (Amersham Corp., Arlington
Heights, IL) for 5min at 20% efficiency corrected
by internal standard. RNA was assayed by the
method of Scott et al. (1956) modified by Hinrichs
et al. (1964).
Crypt depths in coded slides were measured by
ocular micrometry in crypts sectioned from top to
bottom without interruption. Each value reported
represents the mean of measurements from 10
crypts.
Student's t-test for unpaired data, the x2 test and
a two-tailed deviate test for calculation of power
and fl-error was used for statistical analysis.
Results
Overall, 106/115 mice survived. Six mice in the
vanadate-treated groups died during the course of
the experiment. No cause was identified. Four mice
in DMH-treated groups died before the
development of colonic tumours; three were
receiving DMH alone and one was receiving V20-
DMH. Tables I+II give the number of surviving
mice in each tumour-bearing group.
Weight gain (Figure 1) There were no systematic
differences in mean weights among the 6 groups of
mice throughout the 30 weeks of the experiment.
Nucleic acid content (Figure 2) RNA content was
increased in all mice treated with DMH: 14% in
DMH-treated mice, 21% in V10-DMH, and 19%
in V20-DMH. Compared with controls colonic
RNA content was reduced in all mice treated with
vanadate alone: 11% in the V 10 group and 10% in
the V20 group compared with controls.
DNA content was increased in all DMH-treated
mice compared with controls: 18% in DMH-
treated, 8% in V10-DMH, and 12% in V20-DMH.
Table I Number of tumour-bearing animals
DMH VJO-DMH V20-DMH
Animals 20 23 19
Colonic tumours
Benign
(adenomas) 15 17 10
Colorectal
adenocarcinomas 13 16 8
Anal squamous
carcinomas 2 5 2
30 38 20
Table II Number and type of tumours
DMH VIO-DMH V20-DMH
Animals 20 23 19
Colonic tumours
Benign
(adenomas) 32 37 21
Colorectal
adenocarcinomas
papillary 1 3 0
tubular 27 30 16
non-invasive
(in situ) 38 36 33
Anal squamous
carcinomas 1 7 2
99 113 72
DNA specific activity (cpm [3H]TdRmg-1 DNA)
was increased in all treated animals compared with
controls: 180% in V 10-treated mice, 210% in V20,
420% in V 10-DMH, 550% in V20-DMH, and
19% in DMH. DNA specific activity was increased
in DMH-vanadate treated mice compared with
DMH-treated mice: 380% in V(10)-DMH and
490% in V20-DMH.
Crypt depth (Figure 3) Compared with controls
crypts deepened 33% in DMH-treated mice, 23%
in V I0-DMH, and 18% in V20-DMH. There were
no histological abnormalities in mucosa of animals
Rx with vanadium.
Tumours (Tables I and II) The number of mice
bearing benign adenomas, colorectal adeno-
carcinomas, and anal squamous carcinomas at 30
weeks was similar after DMH, V I0-DMH and
V20-DMH.
The distribution of benign and malignant
colorectal tumours was similar in all three DMH-
treated groups. The range of malignant tumours
was from well-differentiated tubular and papillary
adenocarcinomas (12%) to moderately (62%) or
poorly (26%) differentiated carcinomas, with deep
invasion into the muscularis propria.
There was no difference in the distribution of
tumours of the same histological type among
DMH-treated mice, V I0-DMH and V20-DMH.
The mean number of adenomas, colorectal
adenocarcinomas, and anal squamous carcinomas
per mouse was also similar in all three DMH-
treated groups (power 5%, fl-error 21%).
There were no benign or malignant tumours in
control mice or in those treated with vanadate
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Discussion
The level of trace elements in the human diet
influences the development of gastrointestinal
cancers. Dietary molybdenum protects against
oesophageal neoplasia, and a correct balance of
selenium is important in the prevention of colonic
neoplasia (WHO, 1973). Corroborative evidence in
rats indicates a protective action of selenium
against DMH-induced colonic neoplasia. (Jacobs,
1981). Increased levels of vanadium, presumably
resulting from excessive environmental
contamination, are present in the blood of some
patients with cancer (Agrawal, 1978).
Although no specific physiological role has been
identified for vanadium (Simons, 1974), its effects in
vitro include inhibition of enzyme systems and
alteration of cation-anion exchange mechanisms
(Ramasarma, 1981). Perhaps these actions explain
the reduced colonic RNA content in our
experiments as a result of suppression of RNA
synthetic enzymes and the enhanced thymidine
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uptake as a result of increased thymidine flux.
The level of dietary vanadate supplementation is
an important factor in the evaluation of these
experiments. Supplementation was given at levels
both two-fold and four-fold more than those in
industrial environments, where vanadium can
contaminate water by more than 5ppm (Parker,
1978). Vanadium is rapidly absorbed and excreted,
though some probably reaches the colonic lumen
when given in high dosage. Rats achieve optimal
growth rates when dietary vanadium is supplied at
0.1 ppm (Schwarz, 1971), and no symptoms or signs
of toxicity were recognised after diets containing up
to 50ppm vanadium (Parker, 1978). Mice, in our
experiments, drinking water containing 1Oppm and
20ppm vanadate for 30 weeks suffered few deaths
and no loss of weight.
Thus, a diet supplemented for 30 weeks with
vanadate lOppm or 20ppm in drinking water does
not influence the development of large bowel
tumours in DMH-treated mice.
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Figure 1 Animal weights. Each point represents a mean value from all animals in one group. (0), control;
(O), V(10); (C]1), V(20); (/\), DMH; (x), DMH-V(10); (A), DMH-V(20).
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